Redefining Success in IBD Drug Discovery with Human Tissue Models
11 December 2024
Redefining IBD drug discovery with a dual-pronged approach through human bioengineered and fresh tissue.
Harnessing Functional Genomics to Revolutionize Inflammatory Bowel Disease Treatment
07 June 2024
Discover how functional genomics is transforming IBD treatment with groundbreaking research on ETS2's role in inflammation.
The influence of the microbiome on inflammatory bowel disease
18 March 2022
Learn about the the influence of the gut microbiome on inflammatory bowel disease (IBD) and how precision medicine may change the way we treat IBD.
4 reasons human tissues should be used to predict drug bioavailability
29 January 2020
Find out why human tissues should be used to predict drug bioavailability and permeability on the REPROCELL blog.
IBDiscovery: Combining patient and drug discovery data to transform healthcare
16 September 2019
Learn how REPROCELL's IBDisocvery project is combining patient and drug discovery data to transform healthcare.
An Improved Model for IBD Drug Discovery
11 July 2019
Looking to find an improved model for IBD drug discovery? Find out the benefits of human tissue testing on the REPROCELL blog.
Advances in diagnostics, treatments, and frontiers of research in IBD
13 June 2019
Find out the latest advances in diagnostics, treatments, and frontiers of research in IBD on the REPROCELL blog.